Sir Colin Blakemore is Director of the Centre for the Study of the Senses in the School of Advanced Study, University of London and Emeritus Professor Neuroscience at Oxford. He worked in the medical schools of Cambridge and Oxford for more than 40 years and from 2003-7 was Chief Executive of the Medical Research Council. His research has focused on vision, development of the brain, and neurodegenerative disease. Colin has been President of the British Science Association, the British Neuroscience Association, the Physiological Society and the Society of Biology. He is a member of 12 scientific academies, including the Royal Society and the Academy of Medical Sciences, and his honours include the Ralph Gerard Prize (the highest award of the Society for Neuroscience), and both the Faraday Prize and the Ferrier Prize from the Royal Society. He has also been involved in scientific advice to government and in public communication about science, with almost 1,000 TV and radio broadcasts and frequent articles in the press. He was knighted in 2014 for 'service to scientific research, policy and outreach.'
Ilana is Emeritus Professor of Addiction Psychiatry, Keele University; Honorary Consultant Psychiatrist, South Staffordshire and Shropshire Healthcare NHS Trust; and Visiting Professor, St George’s University of London. Prof Crome's current research interests include Mental and physical comorbidity, smoking cessation trials, decision making in substance misusers, suicide and substance misuse, pregnant drug users, addiction along the life course, and the enhancement of training and education in substance misuse in health professionals at all levels. Recent publications include ‘Our invisible addicts’ (2018), a Royal College of Psychiatrists’ report on older substance misusers (co-chair, editor and author) and ‘Substance use and older people’ published by Wiley in 2015 (lead editor), and a book on ‘Substance use in young people’.
Adam Knight is co-founder of Social & Sustainable Capital, an impact investment firm founded in 2012 to support charities and social enterprises by providing them with appropriate capital to allow them to grow and help those most in need in our society today. Adam is Chairman of the London Bitcoin exchange Coinfloor, a board member of The Green Deal Finance Company and SME lender Fleximize. Prior to this Adam ran the global Commodities Alliance, a joint venture between Credit Suisse and Glencore after starting his career as a commodity trader at Goldman Sachs.
Sophie has been Head of Market Development at Power to Change since March 2015. Her experience in the charity and private sectors spans project management, communications, fundraising and grant-making. She has over ten years’ experience in the charity sector with organisations such as the Directory of Social Change and UK Community Foundations and five years as the former CEO of DrugScience.
David Nutt is currently the Edmund J Safra Professor of Neuropsychopharmacology and Head of the Neuropsychopharmacology Unit in the Centre for Academic Psychiatry in the Division of Brain Sciences, Dept of Medicine, Hammersmith Hospital, Imperial College London. He is also visiting professor at the Open University in the UK and Maastricht University in the Netherlands. He currently is the founder Chair of DrugScience and has held many leadership positions in both the UK and European academic scientific and clinical organisations. These include presidencies of the European Brain Council, the British Neuroscience Association, the British Association of Psychopharmacology and the European College of Neuropsychopharmacology as well as Chair of the UK Advisory Council on the Misuse of Drugs. He is a Fellow of the Royal Colleges of Physicians, of Psychiatrists and of the Academy of Medical Sciences. He is also the UK Director of the European Certificate and Masters in Affective Disorders courses and a member of the International Centre for Science in Drug Policy. David has edited the Journal of Psychopharmacology for over twenty five years and acts as the psychiatry drugs advisor to the British National Formulary. He has published over 500 original research papers and a similar number of reviews and books chapters, eight government reports on drugs and 31 books, including one for the general public, ‘Drugs Without the Hot Air’, which won the Transmission book prize in 2014 for Communication of Ideas.
Nick is a British peer, doctor and politician. Nic served as Acting Sergeant in the Suffolk Regiment between 1946 and 1948, and held various junior hospital posts between 1954 and 1957. He was research fellow in paediatrics in Ibadan and Lagos in Nigeria from 1962 to 1965, and lecturer in social medicine at St Thomas's Hospital Medical School in London from 1966 to 1968. Nic is a member of Amicus, Healthlink Worldwide and the Mary Ward Centre. He supports the Mother and Child Foundation, the Caroline Walker Trust and is Honourable Secretary of the National Heart Forum. In the House of Lords he sits on the Labour benches.
Jeff has been MP for Manchester Withington since May 2015, and serves as an Opposition Whip. He was born and raised in south Manchester and gained a degree from the University of Manchester. After university, he worked as an event manager and DJ at festivals and clubs across the country. Prior to becoming an MP, Jeff was a local Councillor in Manchester Withington’s Old Moat ward for 18 years, serving as the Council's Executive Member for Education and Children’s Services and Executive Member for Finance. Away from politics, Jeff is a lifelong Manchester City season ticket holder and takes every opportunity he can to see Bruce Springsteen in concert.
Clare studied physiology at University College London (UCL), followed by postgraduate and postdoctoral research, at the University of Oxford, investigating neurochemical mechanisms that regulate noradrenergic transmission in the brain and periphery. She then returned to UCL where her research interests have focused on the neurobiology of mood and behaviour and the mechanism(s) of action of psychotropic drugs, including those used to treat psychiatric disorders. This work has involved preclinical research in vitro and in vivo, as well as human studies. She is currently Professor (Emerita) of Translational Neuropharmacology at UCL, and a Trustee of the British Pharmacological Society and the Laboratory Animal Science Association. She is also a current member of the Animal Science Committee, which is an independent committee that advises the Home Office on matters relevant to regulation of scientific experiments involving the use of animals. Clare is a former member of Council of the University of London and has served as President of the British Association for Psychopharmacology and the Laboratory Animal Science Association
Dr Roland Archer is Guernsey’s States Analyst, he runs a state-of-the-art analytical laboratory and is responsible for analysing drugs seized locally. He is highly regarded in his field as an independent expert on drug identification, and regularly advises the courts during drug-related cases. Dr Archer also gives technical advice on Guernsey legislation relating to drugs, and acts as an expert witness in local and UK courts. A medicinal chemist with over 19 years’ experience, he is particularly skilled at identifying potential new substances of abuse which have been designed by people seeking to circumvent drug legislation. A particular area of interest for Dr Archer is illicit drug manufacture, he assesses whether a drug may be synthesised illicitly by evaluating the difficulty, time and cost of production using commercially available precursors. He also has an interest in the application of quantum chemistry to predict the outcome of competing reactions during drug synthesis to identify impurity profiles of illicit substances. He has authored over 20 peer-reviewed articles, and is a member of the Chartered Society of Forensic Sciences and The Royal Society of Chemistry.
Stephen Bazire is an Honorary Professor, School of Pharmacy, University of East Anglia in Norwich, a Director of Mistura Enterprise (running the international Choice and Medication website) and Mistura Informatics (MaPPs 2), and a Trustee for Norwich and Central Norfolk Mind. He is the former Chief Pharmacist for Norfolk Mental Health Services (1986-2011) and then Consultant Pharmacist in Medicines Management until retiring from the NHS in January 2015. He is also a Fellow of the Royal Pharmaceutical Society of Great Britain and was awarded an MBE in 2010 for services to pharmacy, and the Guild of Healthcare Pharmacists Gold Medal in 2013. He is probably best known as the author of the Psychotropic Drug Directory, of which there have been 28 editions (latest 2018) and over half a million copies sold worldwide. His special clinical interests include depression, bipolar, adult ADHD, and user and carer information and education on medicines. He has been Chairman and Council member of the College of Mental Health Pharmacy, a member of the Council of British Association for Psychopharmacology, and Visiting Fellow and External Examiner for the School of Pharmaceutical Sciences, Aston University, Birmingham.
Brigitta is a Consultant in Anaesthesia and Pain Management at University London Hospital Trusts, where she has developed a strong interest in acute and chronic pain management. Brigitta has been leading the Acute Pain Service for many years and is actively involved in pain research. Her clinical experience is in vascular and thoracic anaesthesia and also in acute, chronic, cancer and complex pain at UCLH. Brigitta has been an Examiner for the European Society of Anaesthesiology for many years examining in German and English. As chair of SPIN (Specialists in Pain International Network) she supports multidisciplinary pain management in countries struggling to introduce basic services.
Dr Simon Brandt is a Reader in Bioactive Drug Chemistry at the School of Pharmacy and Biomolecular Sciences within Liverpool John Moores University. His research activities and interests focus on the chemistry, analytical and pharmacological properties of psychoactive substances, drugs of abuse and so-called designer drugs, within the context of psychopharmacology, psychiatry, forensic sciences and public health. Dr Brandt obtained a German Diploma in Biochemistry/Molecular Biology with further specialisation in cell structures and pharmacology/toxicology at the University of Hamburg. He holds a PhD in Analytical Chemistry from The University of Manchester (formerly UMIST, United Kingdom). Dr Brandt serves as an Associate Editor of the Wiley Journal Drug Testing and Analysis and as scientific advisor and extended Member of the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Simon also served as a Temporary Advisor to the WHO’s Expert Committee on Drug Dependence.
Eric Carlin is currently undertaking PhD research at Birkbeck College, University of London about how young, socially disadvantaged people can succeed in spite of the odds, and is also project director at SHAAP (the Scottish Health Action on Alcohol Problems). Eric also represents the International Mentor Foundation at the United Nations in Vienna. In 2008 he undertook research to inform the United Nations' Vienna NGO Committee on Drugs as it seeks to improve civic society's engagement with the United Nations. He has twice been elected Vice Chair of this Committee and continues in this role and has three times been elected as Chair of the English Drug Education Forum. From 2000 to 2009 Eric was Chief Executive of Mentor UK, the charity which focuses on developing effective drug misuse prevention activities. Prior to that, from 2005, he was Chief Executive of Angel Drug Services, a London-based street drugs agency. From January 2008 to April 2010 Eric was a member of the UK Government's Advisory Council on the Misuse of Drugs (ACMD). Eric's previous work experience has included developing community participation in planning and delivering Health and Social Services and setting up joint planning systems to deliver Community Care services. He has also managed local HIV prevention and treatment services and an international HIV prevention project for the British Red Cross.
Professor Val Curran's interests span across a wide area of psychopharmacology. Her research is in human experimental, cognitive and clinical psychopharmacology and currently has 4 main foci: 1) transitions from substance use to misuse to addiction to recovery and relapse; 2) neurochemical bases of psychotic symptoms; 3) the differential effects of various cannabinoids upon cognitive, emotional and dependence-related processing; 4) the short and long-term effects of 'recreational' drugs (e.g. alcohol, mephedrone, 'ecstasy', cannabis, ketamine) on cognition, emotion and the brain. Professor Curran was an undergraduate at Cambridge, did her PhD at London University and qualified as a Clinical Psychologist. She went from Research Fellow through to Senior Lecturer at the Institute of Psychiatry from 1984-1995 and since then has worked at UCL. She set up the UCL Clinical Psychopharmacology Unit in 1996 and was appointed Professor of Psychopharmacology in 2000. Val is also Research Lead at the Substance Misuse Services at a Mental Health NHS Trust. She has been a Principal Editor of the journal 'Psychopharmacology' since 2003.
Professor Colin Drummond is Professor of Addiction Psychiatry at the National Addiction Centre, Institute of Psychiatry, King’s College London, and has over 20 years of experience in alcohol misuse research, primarily epidemiological, health service and public health research. He is Chief Investigator for the UK Department of Health National Screening and Brief Intervention Research Programme (SIPS). He chaired the alcohol treatment guideline development group for the National Institute for Health and Clinical Excellence. Professor Drummond is also an advisor to the UK Department of Health and National Treatment Agency for Substance Misuse and is a member of the World Health Organisation’s Expert Committee on Drug and Alcohol Problems. His work has included the development of Models of Care, the national framework for drug and alcohol services in England.
Niamh is Executive Director of Release – the UK’s centre of expertise on drugs and drug laws. Niamh has co-authored Release's two most recent policy papers 'The Numbers in Black And White: Ethnic Disparities In The Policing And Prosecution Of Drug Offences In England And Wales' and ‘A Quiet Revolution: Drug Decriminalisation Policies Across the Globe’. Niamh is also responsible for drafting many of Release's briefings for parliamentarians and policy makers. She has presented at international and national conferences and is regularly invited to comment in the media. Niamh has been a technical advisor to the Global Commission on Drug Policy and is Associate of The London School of Economics IDEAS International Drug Policy Project. She is also a member of the Expert Steering Group for the Global Drug Survey.
Professor Barry Everitt FRS is Professor of Behavioural Neuroscience at the University of Cambridge. He is one of the world’s leading researchers on the neural and psychological mechanisms underlying drug addiction. His recent research concerns the neural basis of compulsive drug taking and vulnerability to addiction as well as the development of novel treatments targeting the aberrant memories that lead to relapse.
Patrick Hargreaves is a school inspector, and a regional PSHE adviser. For 10 years, he was the Drugs and Alcohol Adviser with County Durham Children & Young Peoples’ Services where he was responsible for the delivery of drug and alcohol education to children and young people both in and out of school and for the quality of policies across County Durham's Children & Young People’s settings. He is now independent. He is a member of Drugscope, Alcohol Concern, the Drugs Education Forum, the PSHE Association and NSCoPSE, the national PSE association for advisers, inspectors and consultants. He sat on the Advisory Council on the Misuse of Drugs for 5 years until he resigned in December 2010. He regularly works with the Department for Education and Home Office on educational matters. Previously he has worked in the care system, as a youth worker, taught in all phases of education including special education both in the UK and overseas and set up and managed a Pupil Referral Unit for permanently excluded young people.
Graeme Henderson FBPharmcolS is professor of Pharmacology at the University of Bristol. His research is mainly concerned with the acute and chronic actions of opioid drugs in the brain at the molecular, cellular and behavioural levels. He is an editor of Current Opinion in Pharmacology and an author of a general pharmacology textbook, Rang & Dale's Pharmacology 7th Edition.
Dr John Marsden is a Reader in Addiction Psychology at the Institute of Psychiatry, King’s College London. A senior member of the Department of Addictions, John is Regional Editor for Europe, Africa and Asia for the scientific journal Addiction and a former member of the UK Advisory Council on the Misuse of Drugs. His research interests focus on the development and evaluation of treatments for addiction.
Fiona Measham is Professor of Criminology in the School of Applied Social Sciences at Durham University. Fiona has conducted research for over two decades across a broad area of criminology and social policy, exploring changing trends in legal and illegal drugs; the night time economy and the wider socio-cultural context to consumption. Fiona was appointed to the Advisory Council on the Misuse of Drugs in 2009. She is also Director of The Loop, a not-for-profit drug and alcohol service that introduced the first UK 'front of house' on-site drug testing for public safety in 2016.
After over thirty years of following the Aldous Huxley methods of drug research, Ian joined a lived experience group run by Pathway. For the last three years he has been giving lectures and presentations on all aspects of homelessness and drug use. He was also asked to write an article for the BMJ about how to recognise and look after someone using new psychoactive substances. This lead to his being invited to appear and get involved with many organisations like Drugscience that recognise the value of listening to the people who have been there and done it. He now advise organisations on how to set up lived experience groups and where the cracks in the system are that prevent people getting the help they need.
Dr John Ramsey is an analytical toxicologist and Director of TICTAC Communications Ltd. at St. George’s University of London (SGUL). TICTAC is a commercial database used by UK Healthcare and Law & Order professional to identify drugs. TICTAC analyses the contents of club amnesty bins, attends outdoor music festivals, and test purchases drugs from websites and head shops in order to monitor the appearance on new compounds used as drugs. John is a founder member of the team at SGUL that monitors mortality from volatile substance abuse.
Steve Rolles is Senior Policy Analyst for Transform Drug Policy Foundation, a UK based think tank and charity focused on drug policy and law reform. Lead author on a range of Transform publications including 2009’s ‘After the War on Drugs: Blueprint for Regulation’, Steve has been a regular contributor to the public debate on drug policy and law for over 15 years; in the media, at UK and international events, and at various UN and Government forums around the world. Steve was recently an adviser for the Uruguayan Government in developing their new cannabis regulation model, and was also lead drafter and technical coordinator for the recent ‘Taking control: Pathways to Drug Polices that Work’ report from the Global Commission on Drug Policy. Previously Steve worked for Oxfam and the Medical Research Council, having studied for his Geography BSc at Bristol University and Development Studies MSc at Manchester University.
Ilina Singh is Professor of Science, Ethics & Society at Kings College London. Her work examines the psycho-social and ethical implications of advances in biomedicine and neuroscience for young people and families. Her research has several goals: To investigate the benefits and risks of biomedical and neuroscience technologies for children and young people; to enable evidence-based policy-making in child health and education; and to bring social theory and ethical insights into better alignment with children’s developmental capacities. Ilina is Co-Editor of the journal BioSocieties, and is on the Editorial Board of The American Journal of Bioethics-Neuroscience.
Dr Polly Taylor is a veterinary surgeon who graduated in 1976. After a few years in general practice, Polly specialised in anaesthesia, becoming Reader in Anaesthesia in the Department of Clinical Veterinary Medicine, University of Cambridge. In 2002 she became an independent consultant in Veterinary Anaesthesia, dividing her time between clinical anaesthesia, teaching for Continued Professional Development, anaesthesia for research, and drug registration.
Dr Tim Williams is a consultant addiction psychiatrist within the NHS and honorary clinical lecturer with the University of Bristol. He has published papers on the biological basis of drug and alcohol addiction and written risk assessment documents on ketamine, khat, and GBL. His continuing research is investigating the clinical risk factors that lead to sudden death in drug and alcohol users.
Professor Adam R Winstock is a Consultant Addiction Psychiatrist and Addiction Medicine specialist based in London. He is Honorary Clinical Professor at the Institute of Epidemiolgy and Health Care, University College London. He has published over 120 papers. He is also founder and director of Global Drug Survey which runs the biggest drug survey in the world. He is also the architect of the free online and smartphone apps DrugsMeter and DrinksMeter and and the world's first safer use cannabis guidelines at www.saferuselimits.co